Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Many patients require only one or two doses, then switch to oral maintenance
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that helps regulate appetite, slow digestion, and reduce cravings
However, they are contraindicated in patients with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
What are the ongoing costs
Patient group input was provided by Diabetes Canada and the type 2 Diabetes Experience Exchange (T2DXX) for this review of oral semaglutide (Rybelsus) for T2DM
US$ 24.86
US$ 27.49
US$ 24.57
US$ 20.81
US$ 26.58
